Non-tuberculous Mycobacteria: Medical Treatments
(asked on 13th October 2022) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment she has made of the adequacy of access to innovative treatments for people living with non-tuberculosis mycobacteria in the UK.
This question was answered on 22nd August 2023
On 20 October 2022, NHS England published clinical commissioning policy on the use of nebulised liposomal amikacin for the treatment of non-tuberculous mycobacterial pulmonary disease NTMPD, following an independent review. NHS England concluded that there was enough evidence to make the treatment available.